For more than 10 years, our company deals with the detection of biohazardous materials.

The Ebola virus always played a primary role and we see us confirmed in the decision to have pursued this theme consistently in cooperation with our partners.

Currently an Ebola lateral flow screening test developed in recent years is being evaluated with real specimens in Gueckedou (Guinea). 

As soon as the evaluation shows a successful result, Senova will be able to provide this test to all affected regions. A quality screening test has the potential to make the quarantine management dramatically more efficient and to be able to immediately respond to the risk of infection in case of emergency.

We thank our partners who have supported us in the development, validation and Support:

Institut für Mikrobiologie der Bundeswehr

Institut für Virologie der Philipps-Universität Marburg

Bernhard-Nocht-Institut für Tropenmedizin Hamburg